Domov › Rak trebušne slinavke › New York

Klinične študije za Rak trebušne slinavke v New York

68 študij za Rak trebušne slinavke išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, New York
Research Site, New York

Vključevanje udeležencevFaza 1/2

Starost 18–130 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07562152

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Kings County Hopsital Center, Brooklyn
Queens Cancer Center of Queens Hospital, Jamaica
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
in še 1

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04751435

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
in še 2

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

Columbia University Irving Medical Center, New York

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07621718

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Columbia University Irving Medical Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NYU Langone Medical Center, New York

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Icahn School of Medicine at Mount Sinai, New York
University of Rochester Medical Center, Rochester

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06989437

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Investigative Site US059, Lake Success
Investigative Site US031, New York
Investigative Site US003, New York
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07409272

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Northwell Health / RJ Zuckerberg Cancer Center, Lake Success
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center Main Campus, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NYU Langone Health Perlmutter Cancer Center, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07629960

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Memorial Sloan Kettering Cancer Center - Main Campus, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07450859

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07349537

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0142, Buffalo
Local Institution - 0170, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07492680

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Roswell Park Cancer Institute, Buffalo
Glens Falls Hospital, Glens Falls
Northwell Health/Center for Advanced Medicine, Lake Success
in še 6

Vključevanje udeležencevOpazovalna študija

Starost 50–75 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NYU Langone Health - Long Island, Mineola
New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06400472

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

NYU-Manhattan, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07644559

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Northwell Health Zuckerberg Cancer Center, Lake Success

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06673017

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
David H Koch, Memorial Sloan Kettering Cancer Center, New York
New york cancer and blood specialists - Oncology, Port Jefferson Station
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05245500

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
in še 1

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05837767

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Mount Sinai Hospital, New York
NYP/Weill Cornell Medical Center, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04172532

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Bassett Healthcare Network, Cooperstown
NYU Langone Health, New York
Lenox hill Hospital, New York
in še 1

Vključevanje udeležencev

Starost 18–120 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06698458

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

New York Cancer & Blood Specialists, New York
University of Rochester - Wilmot Cancer Institute, Rochester

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06582017

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
in še 11

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06958328

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Roswell Park Cancer Institute, Buffalo

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07214298

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor
Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
in še 4

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT03334708